ArticleOsteoporosis and sarcopenia2020

Association between elcatonin use and cancer risk in Japan: A follow-up study after a randomized, double-blind, placebo-controlled study of once-weekly elcatonin in primary postmenopausal osteoporosis.

Hiroaki Okamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.